AZI1, also known as centrosomal protein 131 (CEP131), is a protein that is crucial in the centrosomal assembly and the proper functioning of centrioles within cells. Centrosomes are key cellular structures that play a pivotal role in organizing the microtubule network during cell division, and AZI1 is integral to maintaining the structural integrity and the duplication process of centrosomes. It has been identified as a component of the pericentriolar material, which is essential for the recruitment of other proteins that facilitate centrosome cohesion and function. AZI1's role extends to influencing the cell's response to certain stress conditions, particularly in stabilizing microtubules under stress, which is vital for ensuring cellular resilience and adaptability. This function underscores its broader impact on cell cycle regulation and cellular dynamics, positioning AZI1 as a critical player in the maintenance of cellular architecture and in the orchestration of cell division.
The activation of AZI1 within the cell involves several layers of regulation that ensure its function is timely and context-specific. Primarily, the localization of AZI1 to the centrosome is regulated through its interaction with other centrosomal proteins, a process that may be mediated by specific protein domains within AZI1 that facilitate these interactions. Additionally, the expression of AZI1 itself is thought to be tightly controlled by cell-cycle-dependent transcription factors, ensuring that its levels peak during specific phases of the cell cycle, particularly as cells prepare to enter mitosis. Post-translational modifications, such as phosphorylation, also play a critical role in regulating the activity and stability of AZI1. These modifications can influence AZI1's interaction with other centrosomal components, affect its localization, and modify its function in response to cellular signals or stressors. Such precise control mechanisms are essential for the maintenance of centrosome integrity and function throughout the cell cycle, highlighting the sophisticated regulatory network that governs AZI1 activity and its critical roles in cellular physiology.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
LPA stimulates the G-protein coupled receptor LPAR, enhancing vesicle trafficking that engages AZI1. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylyl cyclase, increasing cAMP levels, which in turn may enhance AZI1-involved vesicle trafficking. | ||||||
Chlorpromazine | 50-53-3 | sc-357313 sc-357313A | 5 g 25 g | $61.00 $110.00 | 21 | |
Facilitates clathrin-mediated endocytosis, thus increasing the recruitment of AZI1 to vesicle formation sites. | ||||||
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Increases Ras activation by inhibiting its farnesylation, indirectly affecting endosome sorting where AZI1 is active. | ||||||
Ionomycin, free acid | 56092-81-0 | sc-263405 sc-263405A | 1 mg 5 mg | $96.00 $264.00 | 2 | |
Increases intracellular Ca2+ levels, which can directly activate signaling pathways involving AZI1. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Mimics the action of cAMP, potentially enhancing AZI1-involved vesicle trafficking. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Augments autophagy, a process that may require increased vesicle trafficking involving AZI1. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Activates Phospholipase A2, a key enzyme in vesicle formation where AZI1 might be involved. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
Analog of cAMP; increases PKA activity which may positively affect AZI1-involved pathways. | ||||||
L-α-Phosphatidylinositol sodium salt | 383907-36-6 | sc-221821 | 10 mg | $408.00 | 1 | |
Forms PI3P, which is crucial for vesicle formation and can engage AZI1 in these processes. | ||||||